HPV vaccine cost reimbursement could hinder vaccine access, study suggests
Medical University of South Carolina
Bare minimum reimbursement rates could be a factor in why some clinics may be struggling to offer HPV vaccination in the U.S.
MUSC Hollings Cancer Center researcher Kalyani Sonawane, Ph.D., and a team of researchers from South Carolina and Texas decided to quantify private insurance reimbursement rates for the HPV vaccine after several qualitative studies noted that health care providers were dissatisfied with HPV vaccine reimbursement by private insurance companies.
The results of their investigation were published July 24 in the Annals of Family Medicine.
They found that non-pediatric specialties were reimbursed at lower rates compared with pediatricians.